Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour Mounjaro maintenance dose is the strength at which you stay once your body has adjusted to treatment and your prescriber is satisfied the dose is working well for you. It is not a fixed number — anywhere from 5mg to 15mg can be a maintenance dose, depending on how you respond and what your prescriber decides. Mounjaro is a prescription-only medicine for weight management, so every dose decision sits with a GPhC-registered prescriber who reviews your progress before any change is made.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you collected your first Mounjaro pen, started on 2.5mg, and the nausea was manageable. Four weeks later, your prescriber reviewed your progress and moved you to 5mg. Now, a few months in, someone uses the word 'maintenance' and it's not entirely clear what they mean. It is simpler than it sounds.
Maintenance dose refers to the strength you stay on once you have reached a level that your body tolerates well and that your prescriber judges to be therapeutically right for you. The whole titration process (moving up through 2.5mg, 5mg, 7.5mg and beyond) exists precisely to get you there gradually. The first pen's job is to settle your system, not to drive weight loss. Each step up carries slightly more clinical effect; maintenance is wherever that process stops and stays.
Crucially, there is no single 'correct' maintenance dose for everyone. For some people that is 5mg. For others it is 10mg or 15mg. The full picture of how maintenance doses work on Mounjaro reflects the fact that the licensed treatment range spans six strengths precisely because individual responses vary so much. The NHS medicine information for tirzepatide confirms this step-up approach, with the prescriber directing each transition.
Gastrointestinal side effects (nausea, loose stools, reflux, and sometimes vomiting) are the most common reason people struggle with Mounjaro, and they are strongly dose-dependent. Starting at 2.5mg and moving upwards in roughly four-week intervals gives the gut time to adapt before the dose increases again. Rushing that process trades short-term inconvenience for weeks of feeling genuinely unwell, which most people do not want.
There is also a clinical logic to not always pushing to the maximum. If you are losing weight at a steady, sustainable rate on 7.5mg with minimal side effects, your prescriber may recommend staying there rather than increasing further. The question is not 'how high can we go?' but 'what is the right level for this person?'. That is a judgment made on your actual progress, your tolerance, and your overall health, not a protocol that automatically walks everyone to 15mg.
If you are wondering specifically about the lower end of the scale, the details on whether 5mg counts as a maintenance dose explain when staying at that strength makes clinical sense and when a prescriber might discuss going further. Equally, some patients plateau and need a higher step, the same reasoning applies in both directions.
Reaching your maintenance dose is not the end of clinical involvement. Quite the opposite. In a responsible, supervised programme, you continue to be reviewed at each repeat order, progress assessed, any side effects noted, and the ongoing suitability of the current dose confirmed. If you are not achieving meaningful weight loss after six months on the highest dose you tolerate, your prescriber will discuss next steps with you. That might mean revisiting lifestyle support, considering whether to continue, or exploring other options.
For context on what the evidence says about results over the full treatment course, the SURMOUNT-1 trial published in the New England Journal of Medicine found average weight reductions of around 20–21% at the 15mg maintenance dose over 72 weeks, figures that inform what clinically supervised treatment can achieve, though individual results vary. NICE's appraisal of tirzepatide (TA1026) also notes that continuing treatment should be reviewed if less than 5% weight loss is seen after six months at the highest tolerated dose.
There is one practical timing question our prescribers hear regularly: what if your review falls over a bank holiday or you are away? Ordering ahead, or in good time so your consultation happens before your supply runs low, avoids an unnecessary gap. Orders placed before 12pm on a working day are dispatched the same day once approved, arriving with DPD the next working day, but it is worth building in a small buffer around holiday weeks.
If private treatment costs factor into your planning, the Mounjaro price and cost context page explains how private pricing is structured and what a legitimate quoted price should include. And if you are still in the early stages of understanding the full treatment journey, the overview of all Mounjaro maintenance doses lays out the complete licensed range and what each level means clinically.
The conversation is simpler than many patients expect. Your prescriber wants to know three things: how your weight is tracking, how well you are tolerating the current dose, and whether anything has changed in your health since the last review. You do not need to have prepared clinical arguments. Honest answers to those three areas give the prescriber everything needed to make the right recommendation.
If you are not yet on Mounjaro and are trying to understand what the journey looks like before starting, that groundwork is genuinely useful. Understanding that 2.5mg is an adjustment phase and that you will not stay there long (and that maintenance is wherever you land once the titration finds its level) sets realistic expectations from day one. You can read more about the 2.5mg starting dose and why it is not a maintenance dose if that part of the process is still unclear.
At nume, a named prescriber reviews your consultation personally, not software, not a generic screening form passed to a team. That means the maintenance-dose conversation reflects your specific case. When you are ready to start or to transfer an existing treatment, speak to our prescribers through a free consultation and get a clinical view based on your actual situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.